• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Namering, endocapsular
Generic Namering, endocapsular
kapuzinerweg 12
stuttgart, wurttemberg-baden D-703-7037
PMA NumberP010059
Supplement NumberS003
Date Received03/19/2007
Decision Date05/22/2009
Product Code
MRJ[ Registered Establishments with MRJ ]
Advisory Committee Ophthalmic
Supplement Typereal-time process
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the addition of capsular tension rings (ctrs) models1g, 2s, 6d, 6e, and 10c and change in packaging to incorporate the morcher injector preloaded with ctr models 14, 14a, and 14c. The device, as modified, will be marketed under the trade name morcher capsular tension rings (models 1g, 2s, 6d, 6e, and 10c) and eyejet ctr and is indicated for the stabilization of the crystalline lens capsule in the presence of weak orpartially absent zonules in adult patients undergoing cataract extraction with intraocular lensimplantation. Conditions associated with weak or partially absent zonules may include primaryzonular weakness (e. G. , marfan's syndrome), secondary zonular weakness (e. G. , trauma orvitrectomy), cases of zonulysis, cases of pseudoexfoliation and cases of marchesani¿s syndrome.